2017-06-21 15:16:22 |
Admission to Official List |
1 |
https://app.sharelinktechnologies.com/announcement/asx/5178d251ba86007b9a93c0dd78e59502 |
Admission to Official List
|
2017-06-21 15:18:18 |
ASX Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e42f50aa5b028e11671d1069406a4929 |
Admission to Official List
Commencement of Official Quotation
|
2017-06-21 15:21:25 |
Pre-quotation info- includes Top 20 & Distribution Schedule |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3be1ba3f1cc1a7ceab4a7271243cbaf4 |
Security holder details - Other
Admission to Official List
|
2017-06-21 15:22:08 |
Appendix 1A and Information Form & Checklist |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1c7315e7031c3b7086509e0219f4641a |
Admission to Official List
Company Administration - Other
|
2017-06-21 15:23:54 |
Replacement Prospectus |
0 |
https://app.sharelinktechnologies.com/announcement/asx/319cdd44a8bf79baa45def25e296af23 |
Admission to Official List
|
2017-06-21 15:24:39 |
Constitution |
0 |
https://app.sharelinktechnologies.com/announcement/asx/617ab6135a843d739d6a453e6065e295 |
Admission to Official List
|
2017-06-21 15:26:25 |
Audited accounts to 31 December 2016 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/de6d2ba7808f4a5a13f427bc917a082e |
Admission to Official List
|
2017-06-21 15:28:42 |
Senior Scientific, LLC audited accounts 1 Jan to 17 Nov '16 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/22afbc9bb0d8994696cfefce8f524ebd |
Admission to Official List
|
2017-06-21 15:32:26 |
Senior Scientifc, LLC audited accounts 2014 & 2015 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/724dca35f0d7e6e30aa24d1c2e7d8d02 |
Admission to Official List
|
2017-06-21 15:32:49 |
Securities Trading Policy |
0 |
https://app.sharelinktechnologies.com/announcement/asx/36f0d8ce37effe3cdfe54969afb310d5 |
Admission to Official List
|
2017-06-21 15:33:57 |
Long Term Incentive Plan |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4928d40c622fde214e7820f3ea237a4f |
Admission to Official List
Company Administration - Other
|
2017-06-22 10:01:37 |
Imagion Biosystems lists on ASX |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7b469006416376637b1930797ad6fa5f |
Company Administration - Other
|
2017-06-22 10:02:04 |
Investor Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/80ccaccc1b11719a3938cec9ee0dea0a |
|
2017-06-28 09:04:25 |
Initial Director's Interest Notice (x6) |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9e7f0ad2e1a408b18e6cef51400f18de |
Initial Director's Interest Notice
|
2017-07-10 10:00:19 |
Podcast Interview with Health Professional Radio |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d6358d1068a744f75ba4fc2f1c0ec60e |
|
2017-07-12 09:48:37 |
Imagion Biosystems identifies key operational objectives |
1 |
https://app.sharelinktechnologies.com/announcement/asx/dee45ed87590b1f4edf7a7a96b6ab5ce |
|
2017-07-20 12:45:08 |
Becoming a substantial holder/IBX |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4604985f5a98ce25a511e3e26bd055b6 |
Becoming a substantial holder
|
2017-07-31 11:00:57 |
Appendix 4C & Restated Statements for year ended 31 Dec 2016 |
1 |
https://app.sharelinktechnologies.com/announcement/asx/099c8d0b3e92c4c446e3eb38c167f1f9 |
Commitments Test Entity - Second Quarter Report
|
2017-08-15 11:32:32 |
Imagion Biosystems Initiates MagSense Instrument Development |
1 |
https://app.sharelinktechnologies.com/announcement/asx/664a3b6f521da9c90892955d20d6296c |
|
2017-08-31 12:19:16 |
Appendix 4D and Half-Year Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/735df5eaadfaf29ab2c5c376da96008d |
Half Year Directors' Statement
Half Year Directors' Report
|
2017-10-10 09:34:54 |
Imagion Biosystems Secures Nanoparticle Manufacturer |
1 |
https://app.sharelinktechnologies.com/announcement/asx/654f5301773ba3426dbe0c6e60827262 |
|
2017-10-25 10:04:33 |
Investor Update |
0 |
https://app.sharelinktechnologies.com/announcement/asx/af9aad84381a8a8341303b8129466f85 |
|
2017-10-31 10:07:13 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/e21152d10128a92df460b7987c560d4f |
Commitments Test Entity - Third Quarter Report
|
2017-11-24 12:59:10 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f2c80998ee6ad5b1151108dfcf4f4b12 |
Change of Director's Interest Notice
|
2017-12-06 10:50:58 |
Investor Conference Call |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3910042b1b2e08d550e7f624007573db |
|
2017-12-12 11:06:08 |
Investor Update |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9e8bc0629ae8bf6990dcb8de69bf190f |
|
2018-01-23 17:09:05 |
Release of shares from escrow |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4fa110be53912e8107197a8cf60c872c |
|
2018-01-31 08:50:52 |
Quarterly Update and Appendix 4C |
1 |
https://app.sharelinktechnologies.com/announcement/asx/9a1ab242f6f3684b0fd096ee8161e1d7 |
Commitments Test Entity - Fourth Quarter Report
|
2018-02-12 15:13:24 |
Appendix 3B - Quotation of shares released from escrow |
0 |
https://app.sharelinktechnologies.com/announcement/asx/eb5e7aa08f58368bf5fdf52ad9cd0076 |
|
2018-02-12 15:16:39 |
Notice of change of interests of substantial holder - IBX |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b20e03b1110d23e5827b60e0922e3042 |
Change in substantial holding
|
2018-02-22 10:49:22 |
IBX appoints Vice President of Clinical Research |
0 |
https://app.sharelinktechnologies.com/announcement/asx/21b75f0d84797f34cad2da850e18fe7d |
Company Administration - Other
|
2018-02-28 17:53:41 |
FY2017 Appendix 4E and Financial Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/c92a5d0a90f55ba67320e60c6f1bbd29 |
Full Year Directors' Statement
Full Year Directors' Report
|
2018-04-03 09:22:56 |
IBX Announces Relocation of U.S. Operations to San Diego |
1 |
https://app.sharelinktechnologies.com/announcement/asx/711b940a181022680d9cbfdf74958e1f |
|
2018-04-04 09:08:18 |
Imagion Biosystems Reports Progress on Regulatory Pathway |
0 |
https://app.sharelinktechnologies.com/announcement/asx/949ccab7d5b311d3ef17ee8e9ab5053c |
|
2018-04-24 16:51:26 |
Annual Report to shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e0d69b389950d08fb8e632df56f68a46 |
Full Year Directors' Statement
Full Year Directors' Report
|
2018-04-24 16:57:16 |
Appendix 4G and Corporate Governance Statement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a71693dfc67497dadc807628e27fc0c4 |
|
2018-04-26 10:17:40 |
Director Appointment/Resignation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d3267f3bfe01960668fdbb66eefba42f |
Director Appointment/Resignation
|
2018-04-27 09:23:48 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/11694bddc5594df4afd7975ff0ff41e1 |
Commitments Test Entity - First Quarter Report
|
2018-05-02 16:06:20 |
Notice of Annual General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d75fa70196b69946c3dd6af3b3f1d3d0 |
Notice of Annual General Meeting
|
2018-05-04 16:45:39 |
Initial Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/efccba3c761e58a1a83c3ec6333d3457 |
Initial Director's Interest Notice
|
2018-05-04 16:49:14 |
Final Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a0e101652c22f3b28d4ceb64f34fb400 |
Final Director's Interest Notice
|
2018-05-23 10:50:06 |
MD Anderson Cancer Center Takes Equity Stake in IBX |
1 |
https://app.sharelinktechnologies.com/announcement/asx/56c7cbd18e2c723b655ea22f8e4cdfcb |
Alteration to issued capital
|
2018-05-23 10:54:01 |
Amendment to Notice of Annual General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5735b2cd10d06048062a9920f039842f |
Notice of Meeting - Other
|
2018-05-31 13:26:48 |
Chairman's Address to Shareholders at Annual General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ffa69a2443d159fec1cdb1cd21f5a200 |
Chairman's Address to Shareholders
|
2018-05-31 13:31:13 |
Investor Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/85546b955766db65c2f54959ed533565 |
|
2018-05-31 16:09:54 |
Results of Annual General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/dd1d9a669578826a6d4bcb263b1194b1 |
|
2018-05-31 16:39:24 |
Release of shares from escrow |
0 |
https://app.sharelinktechnologies.com/announcement/asx/af995b8ca88f0f5a0b2f6d4bfdef8c74 |
|
2018-06-06 17:35:03 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/27225ada6554db676039378772a719a4 |
|
2018-06-06 17:42:13 |
Cleansing Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/bf59b6abad0a5c9ac8b3d6ad7d8a467a |
|
2018-06-14 09:45:00 |
Appendix 3Y x 5 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/50246fd8adbafb5481a84435c00ca354 |
Change of Director's Interest Notice
|
2018-06-19 16:42:07 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c6d3a0cfe973af0d48ccb2453764229b |
|
2018-06-19 16:48:53 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ebd3ff7b5d1533eaf2079bc17baf8d1a |
Change in substantial holding
|
2018-07-27 09:24:14 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/5eb546e3a97e1f68309b14fd59908636 |
Commitments Test Entity - Second Quarter Report
|
2018-07-30 16:32:22 |
Appointment of Director and Appendix 3X |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c09c403584114cd4258f9fb7267d417d |
Initial Director's Interest Notice
Director Appointment/Resignation
|
2018-08-17 09:38:45 |
Response to Appendix 4C Query |
1 |
https://app.sharelinktechnologies.com/announcement/asx/02410a569e7cf3c442ae0dd37c1b077b |
|
2018-08-23 16:42:50 |
Half Yearly Report and Accounts |
1 |
https://app.sharelinktechnologies.com/announcement/asx/de4871ae76b948610a7a33352e6b78e2 |
Half Year Directors' Statement
Half Year Directors' Report
|
2018-09-10 08:39:41 |
Imagion Biosystems Hits Nanoparticle Formulation Milestone |
1 |
https://app.sharelinktechnologies.com/announcement/asx/bef0497fefbe761092c1939d95d1e0fe |
|
2018-09-13 09:01:27 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/451daccf4969d3960feee09da07e0b81 |
|
2018-09-17 09:34:19 |
Voluntary Suspension |
1 |
https://app.sharelinktechnologies.com/announcement/asx/fadd1dfb276180db0a9eed81352eea9e |
Suspension from Official Quotation
|
2018-09-20 10:15:55 |
Pro-Rata Non-Renounceable Rights Issue |
1 |
https://app.sharelinktechnologies.com/announcement/asx/b80fc85a92859dc53bc1b98d29af9f2b |
|
2018-09-20 10:16:20 |
Market Announcement - Reinstatement to official quotation |
1 |
https://app.sharelinktechnologies.com/announcement/asx/57d2e31e295e66c8eeb5cad97f4ac674 |
Reinstatement to Official Quotation
|
2018-09-24 09:31:43 |
Rights Issue Offer Document |
1 |
https://app.sharelinktechnologies.com/announcement/asx/75ab8b9710a1a68bc64967d00c033fdf |
|
2018-09-24 09:35:47 |
Appendix 3B - Rights Issue |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b15c56a1d9608883d716b0280294a2ab |
|
2018-09-24 09:36:22 |
Cleansing Notice - Rights Issue |
0 |
https://app.sharelinktechnologies.com/announcement/asx/610da2bc288969b649ed156d27580e7e |
|
2018-09-24 09:39:52 |
Letter to Option Holders - Rights Issue |
0 |
https://app.sharelinktechnologies.com/announcement/asx/48e4fbed485b970c69fee470d02e59c0 |
|
2018-09-25 09:45:10 |
Letter to shareholders - Rights Issue |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4c053f8565452ed9e7852c58d16c5fe6 |
|
2018-10-03 16:11:54 |
Despatch of Rights Issue Offer Documents |
1 |
https://app.sharelinktechnologies.com/announcement/asx/24c93f4f3b9615fd5852a6d7d249e550 |
|
2018-10-19 18:27:41 |
Completion of Rights Issue |
0 |
https://app.sharelinktechnologies.com/announcement/asx/243e64af18dda8eee26b941a1eeae8ea |
|
2018-10-24 17:18:55 |
Appendix 3B - Completion of Rights Issue |
0 |
https://app.sharelinktechnologies.com/announcement/asx/907cdd0217d3de269c3f2248b4b76682 |
|
2018-10-30 10:54:43 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/85e005eafc6b0bd4cd44bc8cbd785791 |
Commitments Test Entity - First Quarter Report
|
2018-10-30 16:13:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5f96a76504a741f53f244137985bcbfa |
Change of Director's Interest Notice
|
2018-11-19 09:16:50 |
Imagion Biosystems Raises $4.3M Via Rights Issue |
1 |
https://app.sharelinktechnologies.com/announcement/asx/f18d86f86fb54e0f13a93c7c89127756 |
|
2018-11-28 16:22:32 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/755071bf82d6faa76680cfcde78c5bb4 |
|
2018-11-28 16:30:07 |
Cleansing Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/93a5c0c9e247bddac0ec76c07f94707c |
|
2018-12-17 09:22:14 |
IBX teams with Planet Innovation to develop MagSense |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b59594291b0d6b38c554a3117e091bc7 |
|
2019-01-30 17:25:05 |
Becoming a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/fad905b3bf2374db36538639c4ba2c8b |
Becoming a substantial holder
|
2019-01-30 17:29:10 |
Becoming a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ce1bd7c66beaad66287c6670a4ac143b |
Becoming a substantial holder
|
2019-01-31 10:22:49 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/253e464b860605e7d6c959b35df39cd9 |
Commitments Test Entity - Fourth Quarter Report
|
2019-02-20 09:35:24 |
Imagion Biosystems initiates toxicology study |
0 |
https://app.sharelinktechnologies.com/announcement/asx/220b62e4d0cde01ed6c76c78ed6adf3e |
|
2019-02-28 15:32:18 |
FY2018 Appendix 4E and Preliminary Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/7f23d85545911e89718278facc5d7387 |
|
2019-03-12 08:44:35 |
IBX receives US patent related to treatment of disease |
1 |
https://app.sharelinktechnologies.com/announcement/asx/bf685adfb0e2269dc08b8eef60fba0ad |
|
2019-03-29 15:25:13 |
FY2018 Financial Report |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4ae33fe758ddfff53a516ae7db8f44e6 |
Full Year Directors' Statement
Full Year Directors' Report
|
2019-04-11 08:39:31 |
IBX receives order related to cancer treatment |
1 |
https://app.sharelinktechnologies.com/announcement/asx/3ca2d239e5b6e6924855f0cf476343d4 |
|
2019-04-26 08:23:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/5254c3c0af86ffabe2228926c1c4c852 |
Commitments Test Entity - First Quarter Report
|
2019-04-30 11:00:13 |
Annual Report to shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5ca23fa7e37325b5ac1b51b9e0be393d |
Full Year Directors' Statement
Full Year Directors' Report
|
2019-04-30 11:00:38 |
Appendix 4G and Corporate Governance Statement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f1e0e196d28d470b5db64523a0aed6b3 |
|
2019-05-02 08:27:41 |
Notice of Annual General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/bb7effe9955fa2f7ce21ddb87bc423b7 |
Notice of Annual General Meeting
|
2019-05-13 13:39:44 |
Imagion Biosystems receives R&D Advanced Overseas Finding |
1 |
https://app.sharelinktechnologies.com/announcement/asx/9ad606c7c7385c3a8f76c22a2e4007fb |
|
2019-05-21 17:05:28 |
Non-Deal Roadshow Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2b64ce1eb1a10c49475b8342ae29c56a |
|
2019-05-23 08:29:48 |
Imagion Biosystems successfully completes toxicology study |
1 |
https://app.sharelinktechnologies.com/announcement/asx/4e11f86f3c90644098cb8dc9b4178df3 |
|
2019-05-31 10:43:16 |
Chairman's Address to Shareholders at Annual General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d2b08795ba33165ac6e1d5d6b47c7b6f |
Chairman's Address to Shareholders
|
2019-05-31 12:37:12 |
Results of Annual General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0f6b795587093bfd87a7494d7f403a8b |
|
2019-06-07 08:27:36 |
Release of Securities Subject to Escrow |
0 |
https://app.sharelinktechnologies.com/announcement/asx/243948d5ae1ae2f366cc95462add80db |
|
2019-06-24 10:38:23 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1f366c95f291604dbb6b29a630aca404 |
|
2019-06-25 17:35:37 |
Ceasing to be a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ba1bfe1287ffb4495855616da6d7d6db |
Ceasing to be a substantial holder
|
2019-06-27 15:42:35 |
Appendix 3Y x 5 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a3a6b40fd897884630044a10309dd0e2 |
Change of Director's Interest Notice
|
2019-06-27 15:45:40 |
Director Resignation - Dr. John Hazle |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c5573139a00f7c4fc276276270021530 |
Director Appointment/Resignation
|
2019-06-28 09:14:05 |
Final Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e759b50284e7f10fe4c84a402d2f2f04 |
Final Director's Interest Notice
|
2019-07-18 09:46:00 |
FDA Breakthrough Device Designation |
1 |
https://app.sharelinktechnologies.com/announcement/asx/9047b2dd7deca32e68d5910c88d4d791 |
|
2019-07-25 09:12:22 |
Imagion Biosystems receives A$2 million in R&D tax incentive |
1 |
https://app.sharelinktechnologies.com/announcement/asx/ca41457f04386735695a4db20f5169b0 |
|
2019-07-25 17:00:50 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c43fd14ef27ebd1d019b2b16a98bd0ad |
Change in substantial holding
|
2019-07-26 10:45:54 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/85184e6d3aa9121a7377cef15261a94e |
Change in substantial holding
|
2019-07-30 09:07:54 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/b129684c4b05c1bedadb5e68675742f0 |
Commitments Test Entity - Second Quarter Report
|
2019-08-06 08:46:39 |
IBX Regulatory Communications Update |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1ae26ce3c6c8b54f868143c5d929bbef |
|
2019-08-23 09:03:33 |
Imagion Biosystem's Newsletter |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0aba0186865d0f2f96a8012da965532e |
|
2019-08-30 08:43:51 |
Appendix 4D and Half Year Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/84dbef3bc05e251c1e4b12f94765a9fa |
Half Year Directors' Statement
Half Year Directors' Report
|
2019-09-09 09:09:23 |
MagSense Utility as a Potential MRI Contrast Agent |
1 |
https://app.sharelinktechnologies.com/announcement/asx/2d746645ef8bd958e378fa5f90194305 |
|
2019-09-09 09:29:34 |
Investor Presentation |
1 |
https://app.sharelinktechnologies.com/announcement/asx/78534154c2273da2fa4e83756436779e |
|
2019-09-30 15:31:09 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/167be962def3fd619c98e700bf3bf218 |
|
2019-09-30 15:32:24 |
Cleansing Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e56507be98ddcdb858941986915933bd |
|
2019-10-02 09:15:35 |
Imagion Biosystems Investor Update |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f660407af75a9667d636f673f279de80 |
|
2019-10-04 16:30:20 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/bc73429016f56f7600946819e847e783 |
|
2019-10-14 08:50:57 |
IBX Establishes Scientific Advisory Board |
0 |
https://app.sharelinktechnologies.com/announcement/asx/04eb4e587a2362290a89d800cb71489d |
Company Administration - Other
|
2019-10-22 16:48:26 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ce3b6d5e5458f511ef8f0b4a0a250475 |
|
2019-10-25 08:49:49 |
Imagion Biosystems Nanoparticle Manufacturing Update |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f3759952d824320aed802505d0a26236 |
|
2019-10-28 07:58:43 |
Investor Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b4f2dec8e46f53cd73a07ed3ddeb7a0a |
|
2019-10-28 19:20:37 |
Pro-Rata Renounceable Rights Issue |
1 |
https://app.sharelinktechnologies.com/announcement/asx/c964280312b3637975c37adc6259c23b |
|
2019-10-28 19:22:57 |
Renounceable Rights Issue Prospectus |
1 |
https://app.sharelinktechnologies.com/announcement/asx/ae622dee6919ad8d1268fc95dd976c3a |
|
2019-10-28 19:23:32 |
Appendix 3B - Renounceable Rights Issue |
0 |
https://app.sharelinktechnologies.com/announcement/asx/202ee109c39fdf73d19ce998048371c5 |
|
2019-10-29 10:05:36 |
Pro-Rata Renounceable Rights Issue - Amended Timetable |
1 |
https://app.sharelinktechnologies.com/announcement/asx/9e5f81bde470ffa8fe28716ceec67fe7 |
|
2019-10-29 11:29:47 |
Pro-Rata Renounceable Rights Issue - Indicative Close Date |
0 |
https://app.sharelinktechnologies.com/announcement/asx/50abbe45bbd4de75eaeec4184ce5f9a5 |
|
2019-10-29 16:28:58 |
Renounceable Rights Issue - Eligible Shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/33c2d26392fb2002d414f00dca8226a0 |
|
2019-10-29 16:29:48 |
Renounceable Rights Issue - Ineligible Shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1f15abe71944b72fbbbffe5ec35bb2f2 |
|
2019-10-31 09:45:20 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/97250751aa51a26f7bc232e0abfb1f82 |
Commitments Test Entity - Third Quarter Report
|
2019-10-31 15:24:02 |
Rights Commence Trading |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0b66ef0785aedb506a1b799d523b990d |
|
2019-11-08 13:35:02 |
Supplementary Prospectus |
1 |
https://app.sharelinktechnologies.com/announcement/asx/e8884ea1c664cfd660901c5cce8dc9c4 |
|
2019-11-08 13:36:12 |
Offer Update and Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8da4ba3e7ae64a60c9365beeecae0f34 |
|
2019-11-13 08:55:00 |
Imagion Biosystems' patent issued in India |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ba47958cb6d988628b4153374e6a1a38 |
|
2019-11-22 09:49:25 |
Completion of Renounceable Rights Issue |
1 |
https://app.sharelinktechnologies.com/announcement/asx/567b7e2aa8d9b670612f3445365e3f49 |
|
2019-11-26 12:05:24 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e6c74f89fca85823bc07e13e01f7484c |
|
2019-11-27 08:53:11 |
Imagion Biosystems receives order to supply nanoparticles |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a5fa3b67ad400e864d25e2977413927a |
|
2019-11-29 13:45:17 |
Ceasing to be a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d375a942708a499561a389f66364d34d |
Ceasing to be a substantial holder
|
2019-12-02 18:00:45 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8c14d587f8e375a8fd53ac81925aea86 |
Change in substantial holding
|
2019-12-09 09:12:10 |
Change of Director's Interest Notice - David LUDVIGSON |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c6f5d476bf99cf447e03a198e84bd9bf |
Change of Director's Interest Notice
|
2019-12-09 09:13:45 |
Change of Director's Interest Notice- Mark VAN ASTEN |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e73bd47d35492a76b0c322e7fa380bab |
Change of Director's Interest Notice
|
2019-12-09 09:14:25 |
Change of Director's Interest Notice - Robert PROULX |
0 |
https://app.sharelinktechnologies.com/announcement/asx/cae99e60926cb43e722ad13bf3d5aa62 |
Change of Director's Interest Notice
|
2019-12-10 18:28:15 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/48e9161577bfd35242e011e83e5485f4 |
|
2019-12-10 18:28:55 |
Cleansing Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3ca435688c70bbe799342d353604698c |
|
2019-12-12 09:23:52 |
Response to ASX App 3Y Query |
0 |
https://app.sharelinktechnologies.com/announcement/asx/74f1d8d56b5d9308446f70f4e13620e9 |
|
2019-12-31 13:21:35 |
Response to ASX price query |
1 |
https://app.sharelinktechnologies.com/announcement/asx/39bbaa88e0d2b8917b2b26d93c07a13f |
|
2020-01-21 16:26:41 |
Appendix 3B - Issue of Employee Options |
0 |
https://app.sharelinktechnologies.com/announcement/asx/73df9adef2d69b04e5e76aa4f858fa67 |
|
2020-01-28 08:27:30 |
Appointment of Vice President Clinical & Regulatory Affairs |
0 |
https://app.sharelinktechnologies.com/announcement/asx/82a6c75eb04fa29d1cc9cf34c078dd8a |
Company Administration - Other
|
2020-01-30 09:35:31 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/061bdfdf24dc6851d6f219fca87a9104 |
Commitments Test Entity - Fourth Quarter Report
|
2020-02-14 17:35:21 |
Ceasing to be a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/63047231cca21d8591e14b4d9b6c9828 |
Ceasing to be a substantial holder
|
2020-02-26 09:27:44 |
Business Update - Manufacturing commences |
1 |
https://app.sharelinktechnologies.com/announcement/asx/9da14991103683188f19107f94d56e1e |
|
2020-02-28 08:55:14 |
Appendix 4E and 2019 Full Year Results |
1 |
https://app.sharelinktechnologies.com/announcement/asx/419c274b2fef5fb80a0656b24ac2c405 |
|
2020-03-02 08:36:04 |
IBX General Investor Presentation - March 2020 |
1 |
https://app.sharelinktechnologies.com/announcement/asx/f74a1ff8b15280eb2fc37dc4af5e5874 |
|
2020-03-04 16:17:45 |
Change of Company Registered Address |
0 |
https://app.sharelinktechnologies.com/announcement/asx/fbf11fd79d9b27f0353212e85e3ab5f9 |
Details of Registered office address
|
2020-03-23 09:52:54 |
Trading halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/49a9a36c98126404015b1f2d7f591f41 |
|
2020-03-25 10:20:28 |
Pro-Rata Renounceable Rights Issue |
1 |
https://app.sharelinktechnologies.com/announcement/asx/a53a38fa172ed13d6e982d0eec8c745d |
|
2020-03-25 10:59:53 |
Appendix 3B - Renounceable Rights Issue |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5713fcf88e78dde5c16c4f7444505f40 |
|
2020-03-25 11:06:58 |
Renounceable Rights Issue Prospectus |
1 |
https://app.sharelinktechnologies.com/announcement/asx/8108d53d878f0557efaa29e2c945fd1b |
|
2020-03-25 12:21:53 |
Change to Board of Directors - Director Resignation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c65e842cfeaa408f4072f7f7fe10a113 |
Director Appointment/Resignation
|
2020-03-27 13:57:28 |
Rights Trading Commences |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6de8815bd2806fbfaed9247eef0f2e5b |
|
2020-03-31 16:54:38 |
Audited Financial Statements |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6e256e9d810c74c8bb7b5c3fcc3f5443 |
Full Year Directors' Statement
Full Year Directors' Report
|
2020-04-01 13:20:19 |
Dispatch of the Renounceable Rights Issue Prospectus |
0 |
https://app.sharelinktechnologies.com/announcement/asx/54ff6b701bb97590b835cf6a0ebfe593 |
|
2020-04-02 16:02:07 |
Final Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/832f22df03fb9be8626f005f87e0dfb2 |
Final Director's Interest Notice
|
2020-04-08 13:31:46 |
2019 R&D Tax Refund |
1 |
https://app.sharelinktechnologies.com/announcement/asx/99fb16f9b8fbededa2edead7745c39d8 |
Company Administration - Other
|
2020-04-23 09:26:44 |
Supplementary Prospectus |
1 |
https://app.sharelinktechnologies.com/announcement/asx/8ab6669ae01f6beba489ead38cd17133 |
|
2020-04-23 09:29:09 |
Imagion Rights Issue Oversubscribed Raising $3 Million |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b1562c9aefacab7b2e624d5a9104e444 |
|
2020-04-24 09:43:06 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/969d227bd611494f284b7b659656dfa9 |
|
2020-04-28 09:39:08 |
Proposed issue of Securities - IBX |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e94dd33e10507d6155ed21e0b565c044 |
|
2020-04-28 09:47:03 |
Imagion Updates Capital Raise to $2.5 Million |
1 |
https://app.sharelinktechnologies.com/announcement/asx/1706090df469983358d2138c172ddc3f |
|
2020-04-28 09:47:43 |
Second Supplementary Prospectus |
1 |
https://app.sharelinktechnologies.com/announcement/asx/44b6e9f95ff1e6e8cf49fc7309ad7ba9 |
|
2020-04-28 11:55:49 |
Appendix 2A - Renounceable Rights Issue and Placement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/388a4734d3bcb54483fe09403134f9dd |
Appendix 2A (Application for Quotation of Securities
|
2020-04-29 10:15:31 |
Appendix 4C - Quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/516b64602df3b8e3c9504e38fceb95dd |
Commitments Test Entity - First Quarter Report
Commitments Test Entity - First Quarter Activity Report
|
2020-04-29 14:46:17 |
Appendix 2A - Vesting of Performance Rights |
0 |
https://app.sharelinktechnologies.com/announcement/asx/83cb9f8c7c2e778db1985e3bf8b4f19d |
Appendix 2A (Application for Quotation of Securities
|
2020-04-30 16:23:40 |
Annual Report to shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/297e5632bf18f05940889e09e0b5b4fb |
Full Year Directors' Statement
Full Year Directors' Report
|
2020-04-30 16:35:10 |
Appendix 4G and Corporate Governance Statement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/95463eef623375e614b6bce3ba18c450 |
|
2020-05-01 14:59:33 |
Change of Director's Interest Notice - Robert Proulx |
0 |
https://app.sharelinktechnologies.com/announcement/asx/13a4b6b0b7931473164a85d77bbf5e7b |
Change of Director's Interest Notice
|
2020-05-01 14:59:43 |
Change of Director's Interest Notice - Michael Harsh |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9efcd84b977f7f318e35f04332df5737 |
Change of Director's Interest Notice
|
2020-05-01 14:59:58 |
Change of Director's Interest Notice - Mark Van Asten |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3cf30e857c265040675760af8c474696 |
Change of Director's Interest Notice
|
2020-05-01 15:00:13 |
Change of Director's Interest Notice - Jovanka Naumoska |
0 |
https://app.sharelinktechnologies.com/announcement/asx/29c39109c4c2a0c22dd218cc67bf7ec8 |
Change of Director's Interest Notice
|
2020-05-01 15:00:23 |
Change of Director's Interest Notice - David Ludvigson |
0 |
https://app.sharelinktechnologies.com/announcement/asx/15927a7ff4d895f2f2096de9478fac0e |
Change of Director's Interest Notice
|
2020-05-11 09:35:08 |
Imagion appoints new Non-Executive Director |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ba328362204417f1245a452e5a5d8c05 |
Director Appointment/Resignation
|
2020-05-11 09:35:23 |
Initial Director's Interest Notice - Dianne Angus |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1a0b5d08abeb9b552f8b728162f39b40 |
Initial Director's Interest Notice
|
2020-05-14 16:20:49 |
Imagion Biosystems May 2020 Investor Newsletter |
0 |
https://app.sharelinktechnologies.com/announcement/asx/35384e1ad9e247de544aa631cb345eab |
|
2020-05-19 09:49:44 |
Imagion Nanoparticles used in Viral Therapy Research |
0 |
https://app.sharelinktechnologies.com/announcement/asx/da11f990680bf954aa6321d2b2f36e7e |
|
2020-05-20 09:19:21 |
Imagion establishes collaboration with Siemens Healthineers |
1 |
https://app.sharelinktechnologies.com/announcement/asx/28c972bbed1d63f18c7ea1f16b2799e3 |
|
2020-05-26 08:59:02 |
Imagion Nanoparticle Manufacturing Update |
0 |
https://app.sharelinktechnologies.com/announcement/asx/bc386268b3cbffb3187a131be116c12e |
|
2020-06-19 13:17:53 |
IBX AGM - Communication to Shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f0f5b54b40f2ed00256d08a75675133b |
Notice of Meeting - Other
|
2020-06-19 13:23:48 |
Notice of Annual General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7a8907e17f114b324f67d0c317530ab3 |
Notice of Annual General Meeting
|
2020-06-22 09:26:12 |
Clinical Study in Australia and Webcast |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7fd1eb6c4cb03bbf7bf7d53ddc4fbb1a |
|
2020-06-23 09:54:19 |
IBX Investor Webcast Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7254c78ca5f3e5e6df6fd8b977865409 |
|
2020-06-23 16:28:51 |
Appendix 2A - Vesting of Performance Rights |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5c3a01b846897f38705389440fea48db |
Appendix 2A (Application for Quotation of Securities
|
2020-06-26 11:27:25 |
Change of Director's Interest Notice - Jovanka Naumoska |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4ecc8b6d16ef126197bf33fb999789c0 |
Change of Director's Interest Notice
|
2020-06-26 11:28:20 |
Change of Director's Interest Notice - Michael Harsh |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1bee4238c0f158139f550aa74dcd8988 |
Change of Director's Interest Notice
|
2020-06-26 11:29:45 |
Change of Director's Interest Notice - Mark Van Asten |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a62235673cfb59cef3bcb352fe01bc19 |
Change of Director's Interest Notice
|
2020-06-26 11:30:30 |
Change of Director's Interest Notice - David Ludvigson |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6d09c59bf50608aba4eb301ad8281e9b |
Change of Director's Interest Notice
|
2020-07-13 09:15:13 |
IBX to access next generation MEMs imaging technology |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4ad74ff46eeb68e2ed508a19e7b7ddd1 |
|
2020-07-14 10:06:42 |
Imagion Biosystems announces transition of CFO role |
0 |
https://app.sharelinktechnologies.com/announcement/asx/71699c9b20d69b36238bbe4f108e00f6 |
Company Administration - Other
|
2020-07-21 17:04:17 |
Research shows Imagion nanoparticles enable low-field MRI |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ae4a6cf197d781da30afa3f6f0998083 |
Company Administration - Other
|
2020-07-22 09:20:20 |
Chairman's Address to Shareholders at Annual General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/59c9e6189d6de838379cbfead2831c3e |
Chairman's Address to Shareholders
|
2020-07-22 12:25:36 |
Results of Annual General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/feea27ee2da286de7cb52d8c6cfa826c |
|
2020-07-27 09:50:49 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/43a4c978870c14b13f460e1376979524 |
|
2020-07-28 10:11:02 |
Appendix 2A - Post AGM Issue of Listed Options (IBXOA) |
0 |
https://app.sharelinktechnologies.com/announcement/asx/02d5e64744d1a74e26d0b0fefffb6bc4 |
Appendix 2A (Application for Quotation of Securities
|
2020-07-29 10:07:48 |
IBX raises $5M in oversubscribed placement |
1 |
https://app.sharelinktechnologies.com/announcement/asx/6e706b4f298803ce031c968f654bb023 |
|
2020-07-29 10:08:08 |
Proposed issue of Securities - IBX |
0 |
https://app.sharelinktechnologies.com/announcement/asx/154197df702d86ee36757093d01646a3 |
|
2020-07-29 10:08:18 |
Proposed issue of Securities - IBX |
0 |
https://app.sharelinktechnologies.com/announcement/asx/bd1c804a9eaf39c9125f60346bba135f |
|
2020-07-29 10:09:03 |
Appendix 4C & Quarterly Activity Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/7282e02939148f9d06d91f37a5258491 |
Commitments Test Entity - Second Quarter Report
Commitments Test Entity - Second Quarter Activity Report
|
2020-07-31 16:46:05 |
Upcoming Release of Shares from Escrow |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d48ffdc9dbe73e503d068f7c6db80f8c |
|
2020-08-04 12:00:37 |
Proposed issue of Securities - IBX |
0 |
https://app.sharelinktechnologies.com/announcement/asx/201b2ec39f294188e00820101131fcb4 |
|
2020-08-04 12:03:17 |
Proposed issue of Securities - IBX |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f2801b6b9b800373926c524b1e06a601 |
|
2020-08-04 12:10:12 |
Appendix 2A - Fully Paid Ordinary Shares |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6269e8b91a29a90ad9a03307da061246 |
Appendix 2A (Application for Quotation of Securities
|
2020-08-04 12:12:22 |
Appendix 2A - IBXOA Options |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2676fcd1486326ae61e07f2b529ec71a |
Appendix 2A (Application for Quotation of Securities
|
2020-08-04 12:16:57 |
Cleansing Notice Under Section 708A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5799c82c37e742ec9a653f0811ce73f0 |
|
2020-08-05 09:35:41 |
Imagion Biosystems Phase I study update |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0c970e909d37b18c02c21a8788d20b32 |
|
2020-08-06 16:22:35 |
Appendix 3G - FY20 Performance Rights & Performance Options |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4f4f1c7418b2344810403deeb826891f |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
2020-08-06 16:25:40 |
Appendix 3G - FY20 Directors Options |
0 |
https://app.sharelinktechnologies.com/announcement/asx/fbc155c10db5fd68d783868f6288df0f |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
2020-08-11 16:27:37 |
Change of Director's Interest Notice - David Ludvigson |
0 |
https://app.sharelinktechnologies.com/announcement/asx/10dd8972a7ccd372fdf7a96126b6df7f |
Change of Director's Interest Notice
|
2020-08-11 16:29:02 |
Change of Director's Interest Notice - Dianne Angus |
0 |
https://app.sharelinktechnologies.com/announcement/asx/eb505169c76714a955d27b1befa5eab9 |
Change of Director's Interest Notice
|
2020-08-11 16:30:07 |
Change of Director's Interest Notice - Jovanka Naumoska |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a535152252a4397cc225782bf9b809b7 |
Change of Director's Interest Notice
|
2020-08-11 16:30:57 |
Change of Director's Interest Notice - Mark Van Asten |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b3c6bc13398fbbc8f4ad262339406ca4 |
Change of Director's Interest Notice
|
2020-08-11 16:32:43 |
Change of Director's Interest Notice - Michael Harsh |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f8335610887fe94c482467d50e2dbfed |
Change of Director's Interest Notice
|
2020-08-11 16:33:12 |
Change of Director's Interest Notice - Robert Proulx |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c403915645bc5ed8be2891c713d00383 |
Change of Director's Interest Notice
|
2020-08-13 09:29:14 |
Response to ASX Price Query |
1 |
https://app.sharelinktechnologies.com/announcement/asx/29fc837c720579aabe09ba75b9df1ed8 |
|
2020-08-18 16:27:18 |
Appendix 2A - Fully Paid Ordinary Shares |
0 |
https://app.sharelinktechnologies.com/announcement/asx/57b0f326d5eae775283f53dfaf78b80e |
Appendix 2A (Application for Quotation of Securities
|
2020-08-18 16:30:13 |
Cleansing Notice Under Section 708A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/53484c65a9a417e0528e20f02bd2601c |
|
2020-08-25 16:59:31 |
Appendix 4D and Half Year Results H1 2020 |
1 |
https://app.sharelinktechnologies.com/announcement/asx/29f1c496f2f6fdd7eb2684ec085d886e |
Half Year Directors' Statement
Half Year Directors' Report
|
2020-08-26 16:29:58 |
Appendix 3G |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9c20027f98496f0d1bbe281c85141a66 |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
2020-08-28 09:39:00 |
Appendix 2A - Fully Paid Ordinary Shares |
0 |
https://app.sharelinktechnologies.com/announcement/asx/80bea812768e0671424b7f0e26d933ee |
Appendix 2A (Application for Quotation of Securities
|
2020-08-28 09:44:10 |
Cleansing Notice Under Section 708A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6d2b71178162563e103f1dae01a29b2f |
|
2020-09-04 16:56:39 |
Appendix 2A - Fully Paid Ordinary Shares |
0 |
https://app.sharelinktechnologies.com/announcement/asx/eba41a7cc789c64a4bed77591849f155 |
Alteration to issued capital
Appendix 2A (Application for Quotation of Securities
|
2020-09-04 16:59:00 |
Cleansing Notice Under Section 708A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0552fb2b4f2e90b3f043f087b3909b77 |
|
2020-09-10 17:12:45 |
Vesting of Performance Rights |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2369ac7475cd48b19c57e01639a64452 |
|
2020-09-10 17:16:20 |
Appendix 2A - Fully Paid Ordinary Shares |
0 |
https://app.sharelinktechnologies.com/announcement/asx/60a99f4fbb698e06f2322a4cef4fccb3 |
Appendix 2A (Application for Quotation of Securities
|
2020-09-11 08:34:15 |
Change of Director's Interest Notice - Robert Proulx |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d0492f0ff0d11e727f0c224a8c5598b4 |
Change of Director's Interest Notice
|
2020-09-22 16:28:08 |
Appendix 2A - Fully Paid Ordinary Shares |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0c27139c7f2592f15d6c08e7e6335d2b |
Appendix 2A (Application for Quotation of Securities
|
2020-09-22 16:30:38 |
Cleansing Notice Under Section 708A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7663202d38b2276fac004a148d8fe7c5 |
|
2020-10-05 16:46:55 |
Appendix 3G |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c1982635fe78e8a09447004d9e24bb65 |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
2020-10-05 16:49:20 |
Issue of Unlisted Performance Options under EIP |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e6f46182011ddb79c2c2a79d6f22a126 |
Company Administration - Other
|
2020-10-07 09:35:30 |
Imagion announces HREC approval for Phase I study |
1 |
https://app.sharelinktechnologies.com/announcement/asx/1bf812a0c2807b4e9813bb707f629b25 |
|
2020-10-19 08:17:45 |
Imagion appoints Geoff Hollis as CFO |
0 |
https://app.sharelinktechnologies.com/announcement/asx/31eb80b3d835e803fffe0c13d46ddcf4 |
Company Administration - Other
|
2020-10-20 17:08:34 |
Appendix 2A - Fully Paid Ordinary Shares |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8c979d7fad94956ef45baadb2f3d4266 |
Appendix 2A (Application for Quotation of Securities
|
2020-10-20 17:10:09 |
Cleansing Notice Under Section 708A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6740dd60570d30345b2ab06a4db69272 |
|
2020-10-22 15:59:28 |
Vesting of Performance Rights |
0 |
https://app.sharelinktechnologies.com/announcement/asx/87faa33f7eeb2a0435a774c7cb70245c |
|
2020-10-22 16:02:09 |
Appendix 2A - Fully Paid Ordinary Shares |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d65538f5e0e6eb8c6d8188eebad8e873 |
Appendix 2A (Application for Quotation of Securities
|
2020-10-22 16:04:08 |
Change of Director's Interest Notice - Robert Proulx |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a6061800097968e84fb31776876fabab |
Change of Director's Interest Notice
|
2020-10-27 16:59:14 |
Appendix 4C & Quarterly Activity Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/9597f0630c8b7149fe0e58a0767245bc |
Commitments Test Entity - Third Quarter Report
Commitments Test Entity - Third Quarter Activity Report
|
2020-11-06 12:03:48 |
Statement Pursuant to Listing Rule 4.7C.3 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/45e0f94607995364b389d7105256464e |
Company Administration - Other
|
2020-11-19 09:38:28 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/b31e020eef9c136c2edb0bf329685b19 |
|
2020-11-23 11:18:58 |
IBX raises $6M in placement |
1 |
https://app.sharelinktechnologies.com/announcement/asx/fd7cea5cde84e539e5c7574a377344ef |
|
2020-11-23 11:19:13 |
Proposed issue of Securities - IBX |
0 |
https://app.sharelinktechnologies.com/announcement/asx/95cf9a3c8b0c901da87fdf80ecf1278e |
|
2020-11-26 09:17:46 |
Appendix 2A - Fully Paid Ordinary Shares |
0 |
https://app.sharelinktechnologies.com/announcement/asx/91f0dc8a64f18b3652da5a9a72ef69dd |
Appendix 2A (Application for Quotation of Securities
|
2020-11-26 09:18:41 |
Cleansing Notice under Section 708A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b03940d3072a971fe9d842dd2068a0ed |
|
2020-11-27 11:24:04 |
IBX Issues New Shares |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f1699031800fa1e6c622b4fe518a1d35 |
Appendix 2A (Application for Quotation of Securities
|
2020-11-27 11:24:49 |
Cleansing Notice under Section 708A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/dae94d6ade7c778ba76500a21d232092 |
|
2020-12-08 09:25:38 |
Resignation and Appointment of Company Secretary |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f5456f52f79cbc81d2677d3fc731c991 |
Company Secretary Appointment/Resignation
|
2020-12-15 12:23:30 |
Appendix 3G |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1574196bc30cad45e051487a05cfd7e8 |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
2020-12-15 12:25:55 |
Issue of Rights & Options under EIP |
0 |
https://app.sharelinktechnologies.com/announcement/asx/010e17b3851e869bef15b42ac2aebb50 |
|
2020-12-16 08:40:46 |
First-in-human study update - Study open for enrolment |
0 |
https://app.sharelinktechnologies.com/announcement/asx/09f92725fac4948d6bea0d6a1234a2aa |
Company Administration - Other
|
2020-12-17 08:25:29 |
Imagion Biosystems December 2020 Investor Newsletter |
0 |
https://app.sharelinktechnologies.com/announcement/asx/34dc8eac58c1e736fa2372d5bf63f816 |
|
2020-12-22 10:52:16 |
Appendix 2A - Fully Paid Ordinary Shares |
0 |
https://app.sharelinktechnologies.com/announcement/asx/be3c8af9770a5f972f1ec38739d05243 |
Appendix 2A (Application for Quotation of Securities
|
2020-12-22 10:53:31 |
Cleansing Notice under Section 708A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/edff96ecdc14d1e78916dd37ac15e291 |
|
2021-01-19 10:19:33 |
Cleansing Notice under Section 708A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c6547805aebd1f535aa63e35b420ea00 |
|
2021-01-19 10:21:28 |
Appendix 2A - Fully Paid Ordinary Shares |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7391fc52034d3930eeff861f5df2bd2c |
Appendix 2A (Application for Quotation of Securities
|
2021-01-21 09:46:33 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/e4a161d2c5ba4eb10cab8517551a6e3f |
Commitments Test Entity - Fourth Quarter Report
Commitments Test Entity - Fourth Quarter Activity Report
|
2021-02-02 13:37:26 |
Cleansing Notice under Section 708A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b775f1c0dc1a36952bab9e48a955ed66 |
|
2021-02-02 13:39:31 |
Appendix 2A - Fully Paid Ordinary Shares |
0 |
https://app.sharelinktechnologies.com/announcement/asx/69a0e2ac731fbf087f1c325052ee7665 |
Appendix 2A (Application for Quotation of Securities
|
2021-02-10 13:34:05 |
Appendix 3G |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ef5e9d8e6379affc18da6133fa2645b6 |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
2021-02-10 13:35:10 |
Issue of unlisted performance options under EIP |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1ee1e1d84a00027bf389225f39ab25e0 |
Company Administration - Other
|
2021-02-19 10:43:22 |
Cleansing Notice under Section 708A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0fc0cb765b3e142c9838a3cf8cce6c3a |
|
2021-02-19 10:45:37 |
Appendix 2A - Fully Paid Ordinary Shares |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d13eee78b515291b936bb15532d31621 |
Appendix 2A (Application for Quotation of Securities
|
2021-02-25 14:07:09 |
Appendix 4E |
1 |
https://app.sharelinktechnologies.com/announcement/asx/e46a568c7785c5afcbfc993cf96733f2 |
|
2021-02-25 14:09:48 |
2020 Annual Report to Shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/00845fb7b37e62e74d3d4bac2590595b |
Full Year Directors' Statement
Full Year Directors' Report
|
2021-02-25 14:10:38 |
Appendix 4G and Corporate Governance Statement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3fe7c414c80494d76ed1d3a539689234 |
|
2021-02-25 14:11:58 |
Full Year Results Release |
1 |
https://app.sharelinktechnologies.com/announcement/asx/b333864ebfa9e5185978406f86435744 |
|
2021-03-05 10:05:04 |
Cleansing Notice under Section 708A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/665cb9e7ef3ecdea8f6036ea4a23b5cb |
|
2021-03-05 10:06:09 |
Appendix 2A - Fully Paid Ordinary Shares |
0 |
https://app.sharelinktechnologies.com/announcement/asx/59b695f6898bfb6c20c52d124a0cc460 |
Appendix 2A (Application for Quotation of Securities
|
2021-03-16 08:48:03 |
Imagion receives CSIRO grant for prostate cancer project |
0 |
https://app.sharelinktechnologies.com/announcement/asx/418266a18234684061fec29232beb483 |
|
2021-03-17 08:17:35 |
Cleansing Notice under Section 708A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/afd8e384f58b9853d096d08485ac8666 |
|
2021-03-17 08:17:45 |
Appendix 2A - Fully Paid Ordinary Shares |
0 |
https://app.sharelinktechnologies.com/announcement/asx/007a733cd435eb4d073decd015b7c0d8 |
Appendix 2A (Application for Quotation of Securities
|
2021-03-29 12:30:53 |
Imagion Biosystems March 2021 Investor Newsletter |
0 |
https://app.sharelinktechnologies.com/announcement/asx/fa371b14068c6612479af4dcf7296bad |
Company Administration - Other
|
2021-04-14 15:50:55 |
Cleansing Notice under Section 708A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/386b3af1e6f92a0858342f49cf294487 |
|
2021-04-14 15:52:50 |
Appendix 2A - Fully Paid Ordinary Shares |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0eb776b9cad8801795a4d1dc05c1ac5c |
Appendix 2A (Application for Quotation of Securities
|
2021-04-27 08:22:50 |
Cleansing Notice under Section 708A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4e7b107093fa8872f056d4db04a54aaf |
|
2021-04-27 08:23:20 |
Appendix 2A - Fully Paid Ordinary Shares |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b6dea7aa6b42e594a99a273c9e6fc1e4 |
Appendix 2A (Application for Quotation of Securities
|
2021-04-27 10:34:40 |
Notice of Annual General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5ed554e28ae38597e0baaeee314bdf03 |
Notice of Annual General Meeting
|
2021-04-29 09:39:15 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/de82704cdb379aa7ea43a28cd0e69a8f |
Commitments Test Entity - Third Quarter Report
Commitments Test Entity - Third Quarter Activity Report
|
2021-05-03 09:49:04 |
Patrys and Imagion collaborate on new cancer imaging agents |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d167e0190c4b2481a8861fc441e0d035 |
|
2021-05-03 09:49:09 |
Imagion and Patrys collaborate on new cancer imaging agents |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a665d602e69f3e251903b8a3d0f62094 |
|
2021-05-11 16:21:57 |
Cleansing Notice under Section 708A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/585eec304bf289feb6d25e3349592193 |
|
2021-05-11 16:23:27 |
Appendix 2A - Fully Paid Ordinary Shares |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ffa6ee76886cd024e257d39453180bd5 |
Appendix 2A (Application for Quotation of Securities
|
2021-05-26 11:45:19 |
First-in-human study update - First patient enrolled |
1 |
https://app.sharelinktechnologies.com/announcement/asx/517a15e7d0ef0a7dedf598173bf472bb |
|
2021-05-28 09:47:44 |
Chairman's Address to Shareholders AGM |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c7259006283738b3c2e5476225ab087f |
Chairman's Address to Shareholders
|
2021-05-28 09:47:59 |
AGM presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/fc29eff7a82b09ca3141456150f5fde6 |
Chairman's Address to Shareholders
|
2021-05-28 11:08:10 |
Results of Annual General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/327eaf9025e3c904563da426ac80a517 |
|
2021-06-01 08:56:07 |
2020 R&D Tax Refund |
1 |
https://app.sharelinktechnologies.com/announcement/asx/e6d9fb38a22145acc68186e9fc4d5a1f |
|
2021-06-07 09:10:03 |
Cleansing Notice under Section 708A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f43d95174e9523968df0ffca4386f6d5 |
|
2021-06-07 09:11:58 |
Appendix 2A - Fully Paid Ordinary Shares |
0 |
https://app.sharelinktechnologies.com/announcement/asx/052de518a0aec455830194eff62d64c8 |
Appendix 2A (Application for Quotation of Securities
|
2021-06-10 16:49:27 |
Issue of unlisted performance options under EIP |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a78c076e4b8d24a6a6422cd96756182e |
Company Administration - Other
|
2021-06-10 18:46:02 |
Notification of cessation of securities - IBX |
0 |
https://app.sharelinktechnologies.com/announcement/asx/26f71afefaa9820c3a7d5cff88e97194 |
|
2021-06-15 08:31:38 |
Notification regarding unquoted securities - IBX |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1453e10dfef29c07226e257aca59cafa |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
2021-06-18 10:29:30 |
Cleansing Notice under Section 708A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e8cdf77668bfd3f795e69c6cec906f58 |
|
2021-06-18 10:30:10 |
Conversion of Listed Options |
0 |
https://app.sharelinktechnologies.com/announcement/asx/966e7aad1c70568df7357da4e5a30325 |
|
2021-06-18 10:32:10 |
Application for quotation of securities - IBX |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1cef17cb03459f31ae214616c5cd7dad |
Appendix 2A (Application for Quotation of Securities
|
2021-06-23 16:57:57 |
Notification of cessation of securities - IBX |
0 |
https://app.sharelinktechnologies.com/announcement/asx/362a412271fb38f767fe06e25e84f43c |
|
2021-07-01 16:59:54 |
Cleansing Notice under Section 708A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/18d014b70c988f1f78cda9dcaf688521 |
|
2021-07-01 17:01:59 |
Conversion of Listed Options |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8371514d4b9dfb8aa530c917f9d9b035 |
Alteration to issued capital
|
2021-07-01 17:03:14 |
Application for quotation of securities - IBX |
0 |
https://app.sharelinktechnologies.com/announcement/asx/fe0d1f866bc88ec8521ddfca8a4b5aa1 |
Appendix 2A (Application for Quotation of Securities
|
2021-07-30 13:43:44 |
Quarterly Activities/Appendix 4C Cash Flow Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/b5a051c4420c97bf9a12f2e63da89519 |
Commitments Test Entity - Second Quarter Report
Commitments Test Entity - Second Quarter Activity Report
|
2021-08-06 14:27:56 |
Notification of cessation of securities - IBX |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ae59f3080924af743e7211c46349d739 |
|
2021-08-12 09:58:29 |
Imagion to develop nanocrystals for treating breast cancer |
0 |
https://app.sharelinktechnologies.com/announcement/asx/68b743adefb78dba502ab980ea8a98a6 |
|
2021-08-16 15:12:44 |
Cleansing Notice under Section 708A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d581ba1c3d58a6d8e6908e8ebe739ed3 |
|
2021-08-16 15:13:29 |
Application for quotation of securities - IBX |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a3f47825403cf97d363dcf71f5737d68 |
Appendix 2A (Application for Quotation of Securities
|
2021-08-17 13:00:57 |
Appendix 4D |
1 |
https://app.sharelinktechnologies.com/announcement/asx/b7bbbe5c2b714adfe3b96d6b32122a3c |
|
2021-08-17 13:02:22 |
Half-Year Financial Report |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4869e814de2969b87adf1a652418b249 |
Half Year Directors' Statement
Half Year Directors' Report
|
2021-08-17 13:03:37 |
Half-year results release |
1 |
https://app.sharelinktechnologies.com/announcement/asx/6862b2759bb50cc93b0574df7b97c577 |
|
2021-08-25 15:17:09 |
Notification of cessation of securities - IBX |
0 |
https://app.sharelinktechnologies.com/announcement/asx/12f2959debebe598bc597787533f5241 |
|
2021-08-27 10:54:24 |
Cleansing Notice under Section 708A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/048cda93bc071185b30be09862d05301 |
|
2021-08-27 10:55:09 |
Application for quotation of securities - IBX |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4cff0ad0911f367027998e26d2e01742 |
Appendix 2A (Application for Quotation of Securities
|
2021-09-10 11:51:17 |
Cleansing Notice under Section 708A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/86b07b3374445c5c0c42d9035432125c |
|
2021-09-10 11:52:02 |
Application for quotation of securities - IBX |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5596689c502db759acf13022eef6ec9b |
Appendix 2A (Application for Quotation of Securities
|
2021-09-16 10:22:39 |
Imagion Biosystems September 2021 Investor Newsletter |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8097e43707f3733bbb6e52c83ed0bbe6 |
Company Administration - Other
|
2021-09-17 10:54:17 |
Cleansing Notice under Section 708A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c166cd99b53cf1336438e9393ccaa748 |
|
2021-09-17 10:54:47 |
Supplementary announcement - IBX / Global Cancer Technology |
0 |
https://app.sharelinktechnologies.com/announcement/asx/eccea734f3760a0eb24569977fc521ad |
|
2021-09-17 10:55:07 |
Application for quotation of securities - IBX |
0 |
https://app.sharelinktechnologies.com/announcement/asx/09174dd2970bd3f03c5d2800646a0329 |
Appendix 2A (Application for Quotation of Securities
|
2021-09-17 11:06:12 |
Notification of cessation of securities - IBX |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d744ad7876deff69c9463b02b6853364 |
|
2021-10-01 10:44:13 |
Cleansing Notice under Section 708A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b3f67080545de8ce76aae30e69c39346 |
|
2021-10-01 10:45:08 |
Application for quotation of securities - IBX |
0 |
https://app.sharelinktechnologies.com/announcement/asx/734b024026042c79013571fcbd728000 |
Appendix 2A (Application for Quotation of Securities
|
2021-10-13 10:40:28 |
Cleansing Notice under Section 708A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d623f30a6277d77af3e460867a90c666 |
|
2021-10-13 10:41:53 |
Application for quotation of securities - IBX |
0 |
https://app.sharelinktechnologies.com/announcement/asx/46d057aaec6872e7336221ddb40555dd |
Appendix 2A (Application for Quotation of Securities
|
2021-10-15 10:38:55 |
Notice to IBXO Option Holders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e587c02583a41d68710e068fe22e2fb8 |
|
2021-10-22 08:19:29 |
Application for quotation of securities - IBX |
0 |
https://app.sharelinktechnologies.com/announcement/asx/01cb986ab2bf7d728f60dfed15491a33 |
Appendix 2A (Application for Quotation of Securities
|
2021-10-22 08:21:43 |
Cleansing Notice under Section 708A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/adea462d25c8856f14ddcaac86e5bc48 |
|
2021-10-28 11:51:52 |
Quarterly Activities/Appendix 4C Cash Flow Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/ebe04f2948117266c7bb772ddf25a18e |
Commitments Test Entity - Third Quarter Report
Commitments Test Entity - Third Quarter Activity Report
|
2021-10-29 11:27:21 |
Cleansing Notice under Section 708A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/76b6c92b984a79ee51956fcc6db4c7ad |
|
2021-10-29 11:28:20 |
Application for quotation of securities - IBX |
0 |
https://app.sharelinktechnologies.com/announcement/asx/94a06890002cf222f591177a690895cf |
Appendix 2A (Application for Quotation of Securities
|
2021-11-05 09:49:06 |
Cleansing Notice under Section 708A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e0eeb5fa8a65cddc8d9592721e25cf6f |
|
2021-11-05 09:50:07 |
Application for quotation of securities - IBX |
0 |
https://app.sharelinktechnologies.com/announcement/asx/609d2c586ae48a1d6e5140dacc312550 |
Appendix 2A (Application for Quotation of Securities
|
2021-11-10 08:28:24 |
Response to ASX Price Query |
1 |
https://app.sharelinktechnologies.com/announcement/asx/bdf1d34986e3ef0bbc15e39f1efedcfd |
|
2021-11-12 09:34:21 |
Cleansing Notice under Section 708A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d90445600b776c2b51052aba2d4fb2c7 |
|
2021-11-12 09:35:16 |
Application for quotation of securities - IBX |
0 |
https://app.sharelinktechnologies.com/announcement/asx/26355c2d1bc41d224dc9c4d557f2272b |
Appendix 2A (Application for Quotation of Securities
|
2021-11-12 09:37:31 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/392538ad50305d56a88ebfc791aead33 |
Change of Director's Interest Notice
|
2021-11-19 12:22:20 |
Cleansing Notice under Section 708A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9d4f87dfa909d84af972a9e2b1be9fcf |
|
2021-11-19 12:23:21 |
Application for quotation of securities - IBX |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7d0cbe5e492a15e2296649299bf5c6d0 |
Appendix 2A (Application for Quotation of Securities
|
2021-11-23 09:33:32 |
Change of Director's Interest Notice X2 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c0e09438ac798fae599d68a2845494b9 |
Change of Director's Interest Notice
|
2021-11-25 11:34:22 |
IBXO Options Underwriting Agreement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f15325d4fc6804351355a96cbec82949 |
|
2021-11-26 12:17:53 |
Cleansing Notice under Section 708A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0b6a1d4e57476ba48fa1cae4cb64cc06 |
|
2021-11-26 12:23:10 |
Application for quotation of securities - IBX |
0 |
https://app.sharelinktechnologies.com/announcement/asx/582588235ebc037a12c445c6587510fd |
Appendix 2A (Application for Quotation of Securities
|
2021-12-02 13:32:15 |
Cleansing Notice under Section 708A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/001e44fba0ff05d1f85cb656afb4c2e6 |
|
2021-12-02 13:33:50 |
Application for quotation of securities - IBX |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c884d44fe0635bf3633ca34c9644f978 |
Appendix 2A (Application for Quotation of Securities
|
2021-12-02 13:34:31 |
IBXO Options Exercise Complete |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d0341e9585d4ce4671a95f1442995651 |
Alteration to issued capital
|
2021-12-16 08:21:42 |
Imagion Biosystems December 2021 Investor Newsletter |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1b81c5bb7b6dacc95fd63efac331ce82 |
Company Administration - Other
|
2021-12-17 13:58:01 |
Remuneration Update and Employee Equity Incentives |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a494c5a73e7f84c2e3d9d41f63f78b25 |
Company Administration - Other
|
2021-12-17 13:58:11 |
Notification regarding unquoted securities - IBX |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2ec278fb9f823337f75670680e4eb78d |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
2022-01-07 12:22:00 |
Cleansing Notice under Section 708A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/17a7506469f52eea586d5fa58b0db4a2 |
|
2022-01-07 12:23:04 |
Application for quotation of securities - IBX |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4d9f19fc0fcf2e9c56339054d8c8b8e5 |
Appendix 2A (Application for Quotation of Securities
|
2022-01-28 09:41:43 |
Quarterly Activities/Appendix 4C Cash Flow Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/ee2eea7bc9793dab9039c2ade4883456 |
Commitments Test Entity - Fourth Quarter Report
Commitments Test Entity - Fourth Quarter Activity Report
|
2022-02-22 08:15:40 |
Issue of unlisted options under Equity Incentive Plan |
0 |
https://app.sharelinktechnologies.com/announcement/asx/cfecedd3dbf12692d8d7eb53486a7d3c |
|
2022-02-22 08:15:55 |
Notification regarding unquoted securities - IBX |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ae2bc66df7dd79ad8629a4e3ebbd6693 |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
2022-02-24 13:54:56 |
Appendix 4E |
1 |
https://app.sharelinktechnologies.com/announcement/asx/7fb5ee76dc58c7d31ce166ea497fdaca |
|
2022-02-24 13:57:11 |
2021 Annual Report to Shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/90bba02994dc27a13f98c3dadb87376e |
Full Year Directors' Statement
Full Year Directors' Report
|
2022-02-24 13:58:06 |
Appendix 4G and Corporate Governance Statement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/28e5631505c0415677c9af8a280bf739 |
|
2022-02-24 14:00:06 |
Full Year Investor Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/efe2dd9bf03c64787b859f7a257cc6d6 |
|
2022-02-24 14:00:06 |
Full Year Results Release |
1 |
https://app.sharelinktechnologies.com/announcement/asx/78681af0ab764f660a9d3f280ae023a0 |
|
2022-03-03 16:09:19 |
Revised Appendix 4G |
0 |
https://app.sharelinktechnologies.com/announcement/asx/fe6e41b14189979324f574cee6bd79ad |
|
2022-03-17 10:24:29 |
First-in-human Study Progress Update |
1 |
https://app.sharelinktechnologies.com/announcement/asx/59fd4d0674ed08c551d7bd85602983fd |
|
2022-04-13 11:05:09 |
Issue of unlisted options under Equity Incentive Plan |
0 |
https://app.sharelinktechnologies.com/announcement/asx/df16d8b4825bcbe2e3778c30968e8cf3 |
|
2022-04-13 11:06:14 |
Notification regarding unquoted securities - IBX |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6f929febcf3c3b712c670fdd00538ef3 |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
2022-04-14 11:24:20 |
Imagion Biosystems April 2022 Investor Newsletter |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6627ed2ebc1627de2585954a3fe88eea |
|
2022-04-22 08:50:58 |
Notice of Annual General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a0f10c30aa42360a33e4f5fa8a105b20 |
Notice of Annual General Meeting
|
2022-04-28 09:09:46 |
Quarterly Activities/Appendix 4C Cash Flow Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/112bcedbd0fb3a3f5810496030c7ca37 |
Commitments Test Entity - First Quarter Report
Commitments Test Entity - First Quarter Activity Report
|
2022-05-25 08:33:18 |
Chairman's Address to Shareholders AGM |
0 |
https://app.sharelinktechnologies.com/announcement/asx/822ce211f0411da2ce5f7b70b5823f58 |
Chairman's Address to Shareholders
|
2022-05-25 08:33:18 |
AGM presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/cab01a954838cc51561a76388294caee |
Notice of Meeting - Other
Chairman's Address to Shareholders
|
2022-05-25 11:38:59 |
Results of Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/180e089aafa891a397df3adb3ed9aa25 |
|
2022-07-29 09:44:48 |
Quarterly Activities/Appendix 4C Cash Flow Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/a84c108607ee91625bcc49e927fb78e3 |
Commitments Test Entity - Second Quarter Report
Commitments Test Entity - Second Quarter Activity Report
|
2022-08-01 11:03:30 |
Notification of cessation of securities - IBX |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4658b56defe20d2f6d1c8d4a6b86673f |
|
2022-08-01 11:07:50 |
Application for quotation of securities - IBX |
0 |
https://app.sharelinktechnologies.com/announcement/asx/13cd64bceaf6f3aab2ec07492a2de39c |
Appendix 2A (Application for Quotation of Securities
|
2022-08-01 11:16:35 |
Notification regarding unquoted securities - IBX |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e866e24469566b07ffd83cd812cc5c40 |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
2022-08-25 08:39:00 |
Appendix 4D |
1 |
https://app.sharelinktechnologies.com/announcement/asx/e392f1ceaa58c1c7624a0bb5d3e09ba1 |
Net Tangible Asset Backing
|
2022-08-25 08:46:00 |
Half-Year Financial Report |
0 |
https://app.sharelinktechnologies.com/announcement/asx/cf22deb5d1798658cec90e77dc16bdfb |
Half Year Directors' Statement
Half Year Directors' Report
|
2022-08-25 08:47:00 |
Half-Year Investor Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/13a57150173e3a43fa4370a248255a53 |
|
2022-08-25 08:48:00 |
Half-Year Results Release |
1 |
https://app.sharelinktechnologies.com/announcement/asx/5ec81e04989cb7a2e69f7c893f6809a0 |
|
2022-09-02 08:35:00 |
Notification regarding unquoted securities - IBX |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ffd6702258b1993d12166f59d04f1b9b |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
2022-09-16 09:29:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/37cb3c2a54bbac4c3e109746bf382ffa |
Change of Director's Interest Notice
|
2022-09-28 08:15:00 |
Prostate cancer research update |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d4784eb5a4d6512283c1ff1792a2ddb4 |
Company Administration - Other
|
2022-10-25 10:41:00 |
2021 R&D Tax Refund |
1 |
https://app.sharelinktechnologies.com/announcement/asx/43670a3f73525a39c7ef38a382334660 |
|
2022-10-28 08:23:00 |
Quarterly Activities/Appendix 4C Cash Flow Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/53d502db6fa76a9a2f49308a575d9f94 |
Commitments Test Entity - Third Quarter Report
Commitments Test Entity - Third Quarter Activity Report
|
2022-10-31 13:54:00 |
Notification regarding unquoted securities - IBX |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6b3de268f90d3e1b6d7164b3051cb4ad |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
2022-10-31 16:07:00 |
Change of Registry Address |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a01e374363e5cc65ca3af1b3a1f5536b |
Details of Share Registry address
|
2022-12-08 08:21:00 |
Positive clinical data reported at breast cancer symposium |
1 |
https://app.sharelinktechnologies.com/announcement/asx/06712fc7257cb8b03361bb0be6eda00b |
|
2022-12-28 08:21:00 |
Notification regarding unquoted securities - IBX |
0 |
https://app.sharelinktechnologies.com/announcement/asx/54e90d5de30b173ad21fb50eeade6954 |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
2023-01-30 09:38:00 |
Quarterly Activities/Appendix 4C Cash Flow Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/c49bd138edc38a47fe6b58dd1f4c0dc8 |
Commitments Test Entity - Fourth Quarter Report
Commitments Test Entity - Fourth Quarter Activity Report
|
2023-02-06 09:25:00 |
Company Update - Phase 1 Study Independent Review |
1 |
https://app.sharelinktechnologies.com/announcement/asx/31fdcf20e53c1e58fb61aa016ce519f6 |
|
2023-02-06 09:27:00 |
Investor Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0be2e75c5f5c4eeb0908857e02fab608 |
|
2023-02-06 09:34:00 |
Investor Webinar |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9106beb9cc4e1da2ed6e884dd1c4bc6f |
|
2023-02-08 10:55:00 |
Investor Webinar Recording |
0 |
https://app.sharelinktechnologies.com/announcement/asx/64fb83b2ce6d7c79f8f92089c580e7db |
|
2023-02-23 09:12:00 |
Investor Webinar Participation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/49a5c3d096eb07697c572be26a03cf1b |
|
2023-02-28 08:24:00 |
Appendix 4E |
1 |
https://app.sharelinktechnologies.com/announcement/asx/45059d7d2576ee570c8b3e47a15bb51b |
|
2023-02-28 08:26:00 |
2022 Annual Report to Shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4098fd359036c0d634877f1168f2aaba |
Full Year Directors' Statement
Full Year Directors' Report
|
2023-02-28 08:27:00 |
Appendix 4G and Corporate Governance Statement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1ab60e5b8f202de4070b24a15bca9770 |
|
2023-03-01 12:34:00 |
Imagion receives 2nd CSIRO grant for prostate cancer project |
0 |
https://app.sharelinktechnologies.com/announcement/asx/87bc338c26ff6058f0572358a0007308 |
|
2023-03-07 09:13:00 |
Non-renounceable Entitlement Offer |
1 |
https://app.sharelinktechnologies.com/announcement/asx/336846c4e259537eec49de8c22d3ad1e |
|
2023-03-07 09:13:00 |
Imagion Secures Growth Funding |
1 |
https://app.sharelinktechnologies.com/announcement/asx/b03e14a18998c4c1d9c6ad8f30780ab1 |
|
2023-03-07 09:13:00 |
Imagion Funding Update |
1 |
https://app.sharelinktechnologies.com/announcement/asx/c0369f6c5c77593a087c51afb9c98381 |
|
2023-03-07 09:15:00 |
Entitlement Offer Offer Booklet |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e8b94366a49ba1ef0fc49a6efc1dd07c |
|
2023-03-07 09:15:00 |
Cleansing Notice - Entitlement Offer |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4c86dda4fd2fccc0c63298127c98d7e7 |
|
2023-03-07 09:16:00 |
Proposed issue of securities - IBX |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1bc72998929604b4604b46ab22888126 |
|
2023-03-07 09:17:00 |
Investor Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9e310eb37d979b8e1c6ce1e5964dfaf5 |
|
2023-03-07 17:47:00 |
Proposed issue of securities - IBX |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8d92e81322bcf8f6c46c553fd1525757 |
|
2023-03-07 17:49:00 |
Proposed issue of securities - IBX |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ec5ff57e6906edb42dccc54788a1a208 |
|
2023-03-07 17:52:00 |
Proposed issue of securities - IBX |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b3c3eabe873feb92e5b899b8ce6ddeaa |
|
2023-03-07 17:56:00 |
Correction to Announcement and Offer Booklet |
0 |
https://app.sharelinktechnologies.com/announcement/asx/decfa37bff1ca78adcec1c475acd0879 |
Company Administration - Other
|
2023-03-14 13:02:00 |
Cleansing Notice - Entitlement Offer |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f6705f3b0531c9ab46bbb86491c56cb6 |
|
2023-03-15 10:13:00 |
Dispatch of Entitlement Offer Documents |
0 |
https://app.sharelinktechnologies.com/announcement/asx/bde36489764ff5b80b12bc91080dba30 |
|
2023-03-15 10:14:00 |
Letter to Shareholders - Entitlement Offer |
0 |
https://app.sharelinktechnologies.com/announcement/asx/13aec9989e409ae3f5458bc8e0934eda |
|
2023-03-15 10:16:00 |
Entitlement Offer Offer Booklet |
0 |
https://app.sharelinktechnologies.com/announcement/asx/31b2e2622e6794481ea19e90b49d8b5c |
|
2023-03-17 16:22:00 |
Cleansing Notice under Section 708A(12C)(e) |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8c1d48383a5e3ad9216f53a961b77ab4 |
|
2023-03-21 15:34:00 |
Convertible Securities Investment |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b331127d350b5d0967b351c8c8fc7abb |
Security holder details - Other
|
2023-03-21 15:36:00 |
Cleansing Notice - Mercer Commencement Shares |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9d5f537b7707c684b32d7b2c009a2a91 |
|
2023-03-21 15:40:00 |
Notification regarding unquoted securities - IBX |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b39863bee46b42f13e96b1fd7da25adb |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
2023-03-21 15:43:00 |
Notification regarding unquoted securities - IBX |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1a2b16e7245bc1d481b785e88c54aecf |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
2023-03-21 15:49:00 |
Application for quotation of securities - IBX |
0 |
https://app.sharelinktechnologies.com/announcement/asx/846cc827a3518b88c45478d912b9bef2 |
Appendix 2A (Application for Quotation of Securities
|